We developed the Veriset™ haemostatic patch based on six years of scientific research and development. It’s designed to help you achieve haemostasis quickly and consistently.([FOOTNOTE=Öllinger R, Mihaljevic AL, Schuhmacher C, et al. A multicentre, randomized clinical trial comparing the Veriset™ haemostatic patch with fibrin sealant for the management of bleeding during hepatic surgery [published online Dec. 27, 2012]. HPB (Oxford). 2013;15(7):548-58. doi: 10.1111/hpb.12009.],[ANCHOR=],[LINK=])
The Veriset™ haemostatic patch is not available for sale in the United States.
|Order Code||Size||Unit of Measure||Quantity|
|HP0204E||2 cm x 4 cm (8 cm2)||Box||6|
|HP0204E1||2 cm x 4 cm||Box||1|
|HP0510E||5 cm x 10 cm (50 cm2)||Box||6|
|HP0510E1||5 cm x 10 cm||Box||1|
|HP0816E||8 cm x 16 cm||Box||6|
|HP0204CVE||2 cm x 4 cm (cutting template)||Box||6|
Unlike any other high-efficacy haemostat, Veriset™ patch is 100% free of human components2 - eliminating the risk of viral transmission.
1. Oxidized regnerated cellulose (Layer 1)
2. Trilysine (Layer 2)
3. Reactive polyethylene glycol (PEG) (Layer 3)
Effective in cases of inhibited coagulation and independent of clotting ability.6
6. Based on internal preclinical study assessing CV and PV models on animals with inhibited platelet activity (heparin, aspirin, Plavix™*). 2010.
Ω Based on serum plasma morphology.